List of works - Rebecca Hoh

A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals

scientific article

A Randomized Controlled Trial Assessing the Effects of Raltegravir Intensification on Endothelial Function in Treated HIV Infection ⬇️

scientific article published on November 1, 2012

A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy

scientific article published on 12 December 2013

A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response

scientific article

Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size

Blood T-cell receptor diversity decreases during the course of HIV infection, but the potential for a diverse repertoire persists ⬇️

scientific article published on February 27, 2012

CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART.

scientific article

Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells

scientific article published on 22 October 2012

Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies

scientific article

Defective proviruses rapidly accumulate during acute HIV-1 infection

scientific article published on 08 August 2016

Different human resting memory CD4+ T cell subsets show similar low inducibility of latent HIV-1 proviruses

scientific article published on 01 January 2020

Early and Delayed Antiretroviral Therapy Results in Comparable Reductions in CD8+ T Cell Exhaustion Marker Expression

scientific article published on 23 March 2017

Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals

scientific article published on 14 October 2019

Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy

scientific article published on 22 October 2008

Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals

scientific article

HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells

scientific article

Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy

scientific article

Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling

scientific article published in 2022

Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses

scientific article

PD-1 blockade potentiates HIV latency reversal ex vivo in CD4 T cells from ART-suppressed individuals

article

Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers

scientific article

Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency

article

Signatures of immune selection in intact and defective proviruses distinguish HIV-1 elite controllers

scientific article published on 15 December 2021

Single-cell transcriptional landscapes reveal HIV-1-driven aberrant host gene transcription as a potential therapeutic target

scientific article published on 01 May 2020

The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time

scientific article published on 25 November 2013

The role of CD32 during HIV-1 infection.

scientific article

Tissue memory CD4+ T cells expressing IL-7 receptor-alpha (CD127) preferentially support latent HIV-1 infection

scientific article published on 30 April 2020

Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection

scientific article published in 2024

List of works by Rebecca Hoh

A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals

A Randomized Controlled Trial Assessing the Effects of Raltegravir Intensification on Endothelial Function in Treated HIV Infection ⬇️

A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy

A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response

Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size

Blood T-cell receptor diversity decreases during the course of HIV infection, but the potential for a diverse repertoire persists ⬇️

CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART.

Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells

Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies

Defective proviruses rapidly accumulate during acute HIV-1 infection

Different human resting memory CD4+ T cell subsets show similar low inducibility of latent HIV-1 proviruses

Early and Delayed Antiretroviral Therapy Results in Comparable Reductions in CD8+ T Cell Exhaustion Marker Expression

Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals

Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy

Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals

HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells

Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy

Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling

Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses

PD-1 blockade potentiates HIV latency reversal ex vivo in CD4 T cells from ART-suppressed individuals

Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers

Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency

Signatures of immune selection in intact and defective proviruses distinguish HIV-1 elite controllers

Single-cell transcriptional landscapes reveal HIV-1-driven aberrant host gene transcription as a potential therapeutic target

The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time

The role of CD32 during HIV-1 infection.

Tissue memory CD4+ T cells expressing IL-7 receptor-alpha (CD127) preferentially support latent HIV-1 infection

Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection